Pathstone Family Office’s PHYSICIANS REALTY TRUST DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$369K Sell
30,303
-8,538
-22% -$118K ﹤0.01% 1194
2023
Q2
$543K Buy
38,841
+2,916
+8% +$41.4K 0.01% 719
2023
Q1
$537K Sell
35,925
-837
-2% -$12.6K 0.01% 661
2022
Q4
$525K Buy
36,762
+21
+0.1% +$305 0.01% 694
2022
Q3
$553K Sell
36,741
-47
-0.1% -$793 0.01% 615
2022
Q2
$642K Buy
36,788
+842
+2% +$14.9K 0.01% 481
2022
Q1
$639K Buy
35,946
+8,080
+29% +$142K 0.01% 459
2021
Q4
$525K Buy
27,866
+3,010
+12% +$55.5K 0.01% 542
2021
Q3
$438K Buy
24,856
+2,499
+11% +$46.2K 0.01% 559
2021
Q2
$413K Buy
+22,357
New +$416K 0.01% 541
2021
Q1
– Sell
-11
Closed – – 1497
2020
Q4
$0 Hold
11
– – ﹤0.01% 1408
2020
Q3
$0 Sell
11
-11
-50% -$196 ﹤0.01% 1066
2020
Q2
$0 Buy
+22
New +$359 ﹤0.01% 1058

Other funds holding DOC

Pathstone Family Office's DOC Position: Q3 2023 in Review

Pathstone Family Office reduced its PHYSICIANS REALTY TRUST (DOC) stake by 22% in Q3 2023, selling an estimated $118K and leaving 30,303 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

Pathstone Family Office first reported a position in DOC in Q2 2020 and has held it in 13 quarters since. The position peaked at $642K in Q2 2022. 361 funds tracked by Wall St. Rank hold DOC as of Q3 2023.

  • Pathstone Family Office held 30,303 shares of PHYSICIANS REALTY TRUST worth $369K as of Q3 2023.
  • Pathstone Family Office sold 8,538 PHYSICIANS REALTY TRUST shares in Q3 2023, an estimated $118K.
  • PHYSICIANS REALTY TRUST made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1194 holding.
  • Pathstone Family Office first reported a position in PHYSICIANS REALTY TRUST in Q2 2020 and has held it in 13 quarters since.
  • Pathstone Family Office's PHYSICIANS REALTY TRUST position peaked at $642K in Q2 2022.
  • 361 funds tracked by Wall St. Rank held PHYSICIANS REALTY TRUST as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.